C arotid artery intima-media thickness (IMT), a measure of subclinical vascular disease, has been associated with structural brain changes 1-3 and reduced cognitive function. [3] [4] [5] [6] [7] [8] [9] [10] [11] However, the majority of previous work on IMT and cognitive function has focused on samples with older adults and results have been inconsistent. [3] [4] [5] [6] [7] [8] [9] [10] [11] Although it is becoming increasingly clear that cognitive impairment and dementia have a long preclinical period and that vascular risk factors are key determinants of cognitive function, 12-21 evidence of whether there is an association between IMT and cognitive function earlier in the life course is yet to be determined.
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August 2015 IMT and cognitive function in a cohort of middle-aged adults who were stroke-free. We hypothesized that greater IMT is associated with worse cognitive performance, above and beyond traditional vascular risk factors.
Methods

Study Population
The CARDIA study is an ongoing prospective cohort study in which participants were aged 18 to 30 years old at baseline in [1985] [1986] . A detailed description of the CARDIA study design and recruitment has been described elsewhere. 26 In brief, participants were recruited from 4 field centers, such as the University of Alabama at Birmingham (Birmingham, AL), the University of Minnesota (Minneapolis, MN), Northwestern University (Chicago, IL), and Kaiser Permanente (Oakland, CA). Recruitment was conducted by telephone or door-todoor in areas where telephone recruitment was not possible. Those recruited were then screened for eligibility, and then invited to participate in the study. All 4 filed centers followed the same eligibility criteria about age, race, residence in the target areas, and health and medical status (participants had to be free of long-term disease or disability). A total of 5115 black and white adult participants were recruited from the 4 field centers and recruitment was balanced within center by sex, age, and education and included 52% blacks and 48% whites. Participants were asked to participate at baseline and at follow-up examinations spanning 25 years. In this analysis, we focus on carotid artery IMT, which we measured at year 20 and on cognitive function, which we assessed 5 years later. We obtained appropriate informed consent from all study participants, and the study was approved by the Institutional Review Boards from each field center and the coordinating center. This analysis was also approved by the Publications and Presentations committee of the CARDIA study. Of the 3498 subjects who participated in the study examination at year 25 (72% of the surviving cohort), we excluded 113 subjects with missing cognitive test battery, 582 participants with missing carotid ultrasound, 8 subjects with prevalent-adjudicated stroke, and 177 subjects with incomplete risk factor data. Our analytic sample included a total of 2618 participants.
Carotid Artery IMT
At year 20, we performed ultrasound studies for all CARDIA participants at end diastole according to a standard protocol followed across all 4 field centers. Sonographers who performed the studies were certified and trained centrally at an ultrasound reading center. We used GE-Logiq-700 (Issaquoah) at all filed centers and used a highresolution transducer operating at a frequency of 13 MHz to image the common carotid artery (CCA) in a real-time imaging sequence. The images were then manually read and analyzed at the central ultrasound reading center and the readers were blinded to the participant's characteristics. Further details can be found in the carotid ultrasound manual. 27 Our predictor of interest is IMT of the CCA. We defined maximum IMT as the mean, in mm, of the maximal IMT of the near and far wall on both the left and right sides. On the basis of 58 replicate studies, the Pearson correlation coefficients were 0.86 for the CCA-IMT.
At year 20, we also assessed stenosis according to visual examination separately for the right and left carotid artery. We defined the presence of stenosis as the development of sufficient atherosclerotic plaque of any type resulting in any narrowing of the lumen at any arterial segment (almost all are 1%-25% narrowing). We used the measure of stenosis in a sensitivity analysis, which we describe later.
Cognitive Function
At year 25, we administered to all CARDIA participants a cognitive battery that included 3 cognitive tests in an attempt to characterize cognitive performance at midlife. The delayed verbal memory test on the Rey Auditory-Verbal Learning Test (range, 0-15) assesses the ability to memorize and retrieve words, with higher score (in words) indicating better performance. 28 The Digit Symbol Substitution Test (range, 0-133) is a subtest of the Wechsler Adult Intelligence Scale and measures performance on speed domains, with higher score (in symbols) indicating better performance. 29 The interference score on the Stroop (executive skills) measures the additional amount of processing needed to respond to 1 stimulus while suppressing another, with higher score (in seconds+errors) indicating worse executive performance. 30 For ease of interpretation, we transformed all cognitive test scores into standardized z scores, with positive values indicating better performance and negative values indicating worse performance.
Other Covariates
CARDIA participants reported their years of education completed, which we categorized into completed high school or less versus more than high school. We classified cigarette smoking as never smoked, former smoker, and current smoker, and we calculated daily alcohol use in mL based on an interviewer-administered questionnaire. Participants reported the amount of time per week spent in 13 categories of physical activity during the past year, and then we calculated the total amount in exercise units, which we then categorized into tertiles of low, moderate, and high intensity. We measured body weight using a calibrated scale and measured height with a vertical ruler. We calculated body mass index (BMI) as weight in kilograms divided by height in meters squared (kg/m2). We measured blood pressure while seated using a standard automated blood pressure measurement monitor (OmROn model HEM907XL; Omron). We ascertained hypertension based on systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or use of antihypertensive medications. We ascertained type 2 diabetes mellitus based on fasting glucose levels ≥126 mg/dL, self-report of oral hypoglycemic medications or insulin, a 2-hour postload glucose ≥200 mg/dL, or a glycated hemoglobin A 1c ≥6.5%. We measured plasma total cholesterol concentrations enzymatically at Northwest Lipids Research Laboratory (Seattle, WA). We assessed kidney function using estimated glomerular filtration rate cystatin C using the equation estimated glomerular filtration rate cys =76.7×cystatin C −1.19 . 31 We assessed symptoms of depression using the 20-item Center for Epidemiological Studies Depression Scale (CES-D; range, 0-60) 32 and then classified participants as having elevated depressive symptoms when CES-D score was ≥16.
Statistical Analysis
We compared mean IMT across categories of baseline characteristics using analysis of variance and estimated the increase of average IMT associated with 1 SD difference for continuous variables. We used multivariable linear regression models to examine the associations between IMT and performance on each of the 3 cognitive tests. We modeled IMT as continuous, and we presented the results for 1 SD increase in IMT. In model assessment, we checked for modification of the effects of IMT by sex, and race/ethnicity, using interaction terms. No sex-based or racial/ethnic-based differences were present. We presented the unadjusted model then adjusted for age, sex, race, and education as potential confounders, then additionally adjusted for factors that lie earlier in the causal pathway, including smoking, physical activity, depressive symptoms, BMI, type 2 diabetes mellitus, hypertension, antihypertension medication use, and kidney function. We included covariates in the adjusted models based on their associations with year 25 cognitive function and year 20 CCA IMT. We assessed potential confounders at year 20. We illustrated the association between IMT and performance on the 3 cognitive tests by presenting the average predicted cognitive scores (z scores) at 2 specific values of IMT, from fitted linear regression models.
We performed 2 sensitivity analyses. First, we examined the associations between IMT at other regions of the carotid artery (the internal carotid artery and bulb/internal carotid artery) and cognitive function. Second, we examined the associations between IMT and cognitive function after excluding subjects with subclinical disease, that is, visible stenosis (n=458). All analyses were performed using Stata version 12.
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Results
Compared with included participants, excluded CARDIA participants at year 25 had larger percentages of black individuals (57% versus 44%), larger percentages of individuals with less than high school education (35% versus 20%), and larger percentages of individuals with baseline elevated depressive symptoms (22% versus 16%). Excluded individuals had slightly higher IMT than included individuals (mean [SD], 0.81 [0.01] versus 0.80 [0.002]). Other baseline demographic, behavioral, and cardiometabolic risk factors did not significantly differ between included and excluded CARDIA participants.
In Table 1 , we present the baseline characteristics of our study sample. The mean age of our participants at baseline was 45.3 years old (SD, 3.6). A total of 37.5% of the participants were obese (BMI, ≥30 kg/m 2 ), 36.4% had hypertension, and 13.6% had type 2 diabetes mellitus. Participants had a mean IMT of 0.80 mm (SD, 0.12; range, 0.5-1.8 mm; Figure 1 ). Year 25 mean cognitive scores were 8.5 (SD, 3.2) for verbal memory, 70.9 (SD, 15.8) for processing speed, and 22.1 (SD, 10.6) for executive function (Table 2) . Results in Table 3 show that being male, black, less educated, a smoker, and having comorbidities such as a BMI ≥30 kg/m 2 , hypertension, and type 2 diabetes mellitus were associated with having greater IMT.
In Table 4 , we present the results of linear regression models of the associations between IMT and performance on the 3 cognitive tests. In unadjusted models, greater IMT (per 1 SD difference of 0.12 mm) was significantly associated with worse performance on all 3 cognitive tests (z scores; verbal memory, −0.17; 95% confidence interval [CI], −0.20 to −0.13; processing speed, −0.23; 95% CI, −0.27 to −0.19; and executive function, −0.17; 95% CI, −0.20 to −0.13). In models adjusted for potential confounders, including age, sex, race, and education, greater IMT remained negatively associated with processing speed and executive function (processing speed, −0.08; 95% CI, −0.11 to −0.04 and executive function, −0.05; 95% CI, −0.10 to −0.02) but not with verbal memory. In other words, with every 1 SD increase in IMT, subjects significantly scored 1.2 points (symbols) lower on the test of processing speed and ≈0.5 s+errors more to respond to the executive function task. Additional adjustment for behavioral risk factors, including smoking, physical activity, and elevated depressive symptoms, attenuated the associations but greater IMT remained significantly associated with processing speed and executive function (processing speed, −0.07; 95% CI, −0.10 to −0.03 and executive function, −0.05; 95% CI, −0.09 to −0.01). Finally, additional adjustment for cardiometabolic risk factors that lie earlier in the causal pathway further attenuated the associations, but greater IMT remained negatively associated with processing speed and borderline associated with executive function (processing speed, −0.06; 95% CI, −0.09 to −0.02 and executive function, −0.03; 95% CI, −0.07 to 0.00) and not with verbal memory.
We present the average predicted cognitive z scores (raw scores) on all the 3 cognitive tests at select values of IMT (IMT of 0.68 corresponding to mean IMT−1 SD; and IMT of 0.92 corresponding to mean IMT+1 SD) from fitted linear regression models adjusted for age, sex, race, and education ( Figure 2 ). For a black male who completed high school education or less and with mean value of age, the average predicted score on verbal memory was −0.82 (95% CI, −0.93 to −0.72; or 5.6 points; 95% CI, 5.3-5.9) at an IMT of 1 SD below the mean and was −0.87 (95% CI, −0.96 to −0.78; or 5.5 points; 95% CI, 5.2-5.8) at an IMT of 1 SD above the mean (P=0.2). The average predicted score on processing speed was −0.90 (95% CI, −1.01 to −0.80; or 55.3 points; 95% CI=53.6-57.0) at an IMT of 1 SD below the mean and CCA indicates common carotid artery; eGFR cys , cystatin C-based estimated glomerular filtration rate; and IMT, intima-media thickness. In sensitivity analysis, we did not find significant associations between IMT at other regions of the carotid artery (bulb/internal carotid artery and internal carotid artery) and cognitive function. In another sensitivity analysis where we excluded subjects with subclinical disease (ie, visible stenosis, n=458), the association between IMT and processing speed remained significant (P<0.01).
Discussion
This is the first study to examine the association between IMT and cognitive function in a cohort of middle-aged adults who were free of stroke. In models adjusted for potential confounders, including age, race, sex, and education, we found that greater IMT was significantly associated with reduced cognitive performance on domains of processing speed and executive function which are key components of cognitive functioning. These associations, especially IMT with processing speed, were independent of sociodemographic and traditional vascular risk factors, therefore, suggesting that IMT may provide additional information in predicting cognitive function independent of these factors. Finally, given our relatively young cohort, our findings underscore the importance of early identification and intervention to delay or prevent atherosclerosis before its clinical manifestation as a way to possibly improve cognitive function.
Our results are supported by several studies including primarily older adults. For example, our results were consistent with the findings from the Beaver Dam study, 7 which found a significant association between carotid IMT and executive function as measured by the Trail Making B test, from regression models adjusted for sociodemographic and behavioral risk factors. Our results were also consistent with the findings from several studies showing a null association between IMT and verbal memory. [3] [4] [5] [6] [7] For example, in the Framingham Offspring Study of stroke-free subjects, 3 higher CCA-IMT was not associated with performance on verbal memory tests, such as the immediate and delayed verbal recall tests. Similarly, in the Tromso Study of stroke-free subjects from Norway, 6 CCA-IMT was not associated with verbal memory. Finally, our results showed an association between IMT and processing speed-this finding was, however, inconsistent with the findings from previous studies including primarily older adults such as the Atherosclerosis Risk in Communities (ARIC) study, 4 the Tromso Study of stroke-free subjects from Norway, 6 and the Beaver Dam study. 7 The latter studies used a measure of IMT averaged across all regions of the carotid artery, which may have obscured potential significant associations at individual regions.
Our results show a significant association between IMT and processing speed but not verbal memory. This domainspecific association between IMT and cognitive function is not surprising as vascular risk factors influence to a greater extent performance on processing speed, and are not necessarily related to memory. 9 Our findings were independent of sociodemographic and vascular risk factors of cognitive function, such as smoking, physical activity, BMI, depressive symptoms, type 2 diabetes mellitus, hypertension, and kidney function thus suggesting that IMT may predict cognitive function, processing speed in particular, in middle-aged adults independent of these risk factors that lie earlier in the causal pathway. While the association between IMT and verbal memory was not statistically significant even in sociodemographic-adjusted models, the association between IMT and executive function was strongly significant and became borderline significant only after adjustment for cardiometabolic risk factors, kidney function in particular. In our study, kidney function was strongly associated with both IMT and cognitive function. Future studies need to address the role of kidney function in the associations between subclinical cardiovascular disease and cognitive function.
Our results show significant associations of cognitive function, processing speed in particular, with IMT of the CCA, but not with other regions of the carotid artery. This is not surprising as compared with the IMT of other regions, IMT of the CCA is suggested to be more strongly associated with blood pressure and stroke, 33 which are, in CCA indicates common carotid artery; eGFR cys , cystatin C-based estimated glomerular filtration rate; HS, high school; and IMT, intima-media thickness.
*Data presented as an increase in average CCA-IMT (SE). 12, 25, 34 and less strongly associated with lipids. In other words, our findings suggest that the relationship between IMT and cognitive function is driven by hypertensive-like changes. Although hypertension is a manifestation of loss of vascular integrity and a precursor for atherosclerosis, the latter has been shown to be present even in the early development of hypertension when blood pressure is slightly elevated. 35 In our study, a total of 6.6% of the participants had nonoptimal systolic blood pressure (≥140 mm Hg) and nearly 8% of the participants had nonoptimal diastolic blood pressure (≥90 mm Hg). When we adjusted for blood pressure instead of hypertension, the associations were only slightly attenuated. Our findings are based on a cohort of middle-aged adults who were stroke-free at baseline, and remained relatively similar after excluding subjects with subclinical disease (ie, obvious plaque deposition). As such, our findings provide support for an early cardiovascular prevention and suggest that IMT developing in an earlier phase of the atherosclerotic process may provide a window of time during which appropriate interventions may delay or prevent cognitive deterioration. This is important as there exist potential therapies, such as statins, that have been shown to slow down the process of atherosclerosis in its subclinical stages. 36, 37 Our work has major strengths that are worth noting. Although previous studies included mostly older adults and thus had an average mean age of ≥60 years, our study was the first to examine the association between IMT and cognitive function strictly at midlife (mean age of 45 years) and thus sheds light on potential mechanisms occurring earlier in the life course. Furthermore, although the effect sizes are relatively small, they are clinically meaningful in light of the relatively younger cohort. The strengths of the associations, especially for processing speed, and statistical significance, which persists beyond traditional cognitive risk factors that lie earlier in the causal pathway, is particularly notable considering mean age in our cohort was around 45 years old. Furthermore, while previous work 4,6,7 focused primarily on an overall measure of IMT averaged across all regions of the carotid artery, we examined separately IMT at the different regions of the carotid artery. Previous studies [3] [4] [5] [6] [7] [8] were either based on international cohorts or on US samples of relatively small size, however, our findings were derived from a large US population-based cohort (n=2618), which gave us enough power to detect clinically significant associations. Finally, our study included validated measures of cognitive performance across several domains thus providing rich findings. However, we did not have measures of cognitive function at baseline when IMT was assessed; as such, we could not assess change in function. Furthermore, given that cognitive function was not assessed until the last study visit, our sample size was smaller than the original cohort. Finally, our findings are based on an observational study and there may be residual confounding.
Summary/Conclusions
In conclusion, our study supports a role for early-life IMT development in influencing key components of cognitive function at midlife, including processing speed, independent of traditional vascular risk factors. Future studies are needed to examine whether early atherosclerotic development is associated with longitudinal cognitive change and whether intervening on the atherosclerotic process may indeed prevent or delay cognitive deterioration. 
Table 4. Adjusted Association of 1 SD* Increase in Common Carotid Artery IMT and Cognitive Function Among CARDIA Participants
Figure 2.
Average predicted standardized cognitive scores at each of the following intima-media thickness levels (mean±1 SD), from age, sex, race, and education-adjusted linear regression models. Predicted for a black male who completed high school education or less, and with mean value of age (45 years old).
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